Summary
Global Positron Emission Tomography (PET) Market to Reach $2.7 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Positron Emission Tomography (PET) estimated at US$1.9 Billion in the year 2022, is projected to reach a revised size of US$2.7 Billion by 2030, growing at aCAGR of 4.8% over the period 2022-2030. PET-CT, one of the segments analyzed in the report, is projected to record 5% CAGR and reach US$2.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the PET-MRI segment is readjusted to a revised 3.9% CAGR for the next 8-year period.
The U.S. Market is Estimated at $512.8 Million, While China is Forecast to Grow at 8.1% CAGR
The Positron Emission Tomography (PET) market in the U.S. is estimated at US$512.8 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$591.3 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.
Select Competitors (Total 42 Featured)
- Advanced Accelerator Applications SA
- Best ABT Molecular Imaging, Inc.
- Curasight A/S
- Digiray Corporation
- DuchemBio, Co., Ltd.
- GE Healthcare
- Hitachi Ltd.
- Neusoft Corporation
- PETsys Electronics SA
- Philips Healthcare
